Trial intelligence / Profile preview

Comparison of two doses of intracoronary adenosine in STEMI patients

IRCT201610308903N2Phase 3Completed

Sponsor
Cardiovascular Research Center
Start
Aug 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of adenosine in myocardial infarction (MI) (2 arms), sponsored by Cardiovascular Research Center. Started Aug 2016; status: completed.

02

Drugs

adenosine
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on IRCT201610308903N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201610308903N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call